C. Janson (Uppsala, Sweden), G. Viegi (Pisa, Italy)
Late-breaking abstract: Nasal symptoms are common in subjects with COPD and concomitant heart disease
A. Lindberg, L. G. Larsson, E. Rönmark, B. Lundbäck (Umeå, Luleå, Gothenburg, Sweden)
|  |
Prevalence of COPD in a rural population in India
S. Salvi, S. Juvekar, J. Londhe, B. Brashier, S. Madas, P. Barnes (Pune, India; London, United Kingdom)
|  |
Using the lower limit of normal to classify lung disease misses at risk people
D. Mannino, E. Diaz (Lexington, United States Of America)
| |
Ten-year trend in the prevalence of chronic cough and phlegm among young adults in Italy
S. Accordini, V. Cappa, I. Cerveri, C. Bombieri, M. Bugiani, L. Casali, L. Cazzoletti, A. Corsico, M. Ferrari, V. Ferretti, A. Fois, F. Locatelli, A. Marcon, M. Olivieri, P. Pirina, R. de Marco (Verona, Pavia, Turin, Perugia, Sassari, Italy)
| |
Costs of COPD by disease severity
S. A. Jansson, H. Backman, A. Stenling, A. Lindberg, E. Rönmark, B. Lundbäck (Luleå, Södertälje, Umeå, Gothenburg, Sweden)
| |
Associations between quantitative computed tomography (qCT) measures of emphysema and mortality
A. Johannessen, T. D. Skorge, T. B. Grydeland, H. Coxson, E. Omenaas, A. Gulsvik, P. Bakke (Bergen, Norway; Vancouver, Canada)
| |
Impact of comorbidities on survival of patients with COPD according to GOLD stages
J. Zagaceta, C. Cabrera, D. Miguel, C. Cote, J. De Torres, J. Marin, C. Casanova, V. Pinto-Plata, S. Carrizo, M. Sanchez-Carpintero, J. Zulueta, B. Celli (Pamplona, Las Palmas de G.C., Zaragoza, Tenerife, Spain; Boston, Bay Pines, United States Of America)
| |
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
D. Au, T. O‘Riordan, C. F. Liu, M. Perkins, J. Toole, C. Bryson (Seattle, United States Of America)
| |